Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Epstein-Barr Virus EBV p23 (AA 1-162) Protein

Origin: Epstein-Barr Virus (EBV) Host: Escherichia coli (E. coli) Recombinant > 95 % pure ELISA, WB
Catalog No. ABIN935324
  • Target
    Epstein-Barr Virus EBV p23
    Protein Type
    Recombinant
    Protein Characteristics
    AA 1-162
    Origin
    Epstein-Barr Virus (EBV)
    Source
    Escherichia coli (E. coli)
    Application
    ELISA, Western Blotting (WB)
    Characteristics
    Purified recombinant EBV p23 protein
    Expression System: E.coli
    Purity
    > 95 % pure
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Supplied as a liquid with 25 mM glycine, pH-9.6, and 50 % glycerol.
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    RT/-20 °C
  • Target
    Epstein-Barr Virus EBV p23
    Target Type
    Viral Protein
    Background
    The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virusof the herpes family (which includes Herpes simplex virusand Cytomegalo virus. On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expressionwhich can be broadly categorized as being lytic cycle or latent cycle. The lytic cycleor productive infection results in staged expression of a host of viral proteinswith the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cellas EBV virions are produced by budding from the infected cell. The latent cycle(lysogenic) programs are those that do not result in production of virions.
    Alternative Names: Epstein-Barr Virus p23 protein, Epstein Barr, EBV HHV4 p123 protein
You are here:
Support